Biotech dominates Ireland's ATRP )Advanced Technology Research Programme) programme:
This article was originally published in Clinica
Over one third of proposals received by Enterprise Ireland's Advanced Technology Research Programme (ATRP) 2001 were in the biotechnology field. Of the 172 proposals applying for a share of the I£11.2 million ($12.3 million) fund, 61 were biotech-related projects. The average funding requested was I£300,000. The aim of the programme is to generate technologies, products or processes that help launch new high-tech companies and to promote industrial competitiveness, reports Irish Biotech News. The programme also provides support for the commercial exploitation of research results. The closing date for applications was May 21; their evaluation is currently underway.